Overview

Neoadjuvant Sequential Therapy in Locally Advanced Mid/Low Rectal Cancer

Status:
Unknown status
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
Compared curative effect,safety and compliance between concurrent chemoradiotherapy and chemo-chemoradio-chemo sequential therapy in locally advanced mid/low rectal cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Harbin Medical University
Treatments:
Capecitabine